Female sexual dysfunction: classification, pathophysiology, and management

Fertility and Sterility

Volumn 88, Issue 5, 2007, Pages 1273-1284

  Raina, Rupesh ^a,b   Pahlajani, Geetu ^a   Khan, Shazia ^b   Gupta, Sajal ^a   Agarwal, Ashok ^a   Zippe, Craig D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Female sexual dysfunction; management of female sexual dysfunction; nerve sparing hysterectomy; treatment of female sexual dysfunction

Indexed keywords

ALPHA INTERMEDIN; ANDROSTENEDIONE; APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; FINASTERIDE; NITRIC OXIDE DONOR; PLACEBO; PRASTERONE; PROSTAGLANDIN; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SILDENAFIL; TADALAFIL; TESTOSTERONE; VARDENAFIL;

ANORGASMIA; CLINICAL FEATURE; CLINICAL TRIAL; CLITORIS; CLITORIS HYPERTROPHY; CYSTECTOMY; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; DYSPAREUNIA; FEMALE; FEMALE SEXUAL DYSFUNCTION; HIRSUTISM; HUMAN; HYSTERECTOMY; ORGASM DISORDER; PATHOPHYSIOLOGY; PELVIS CANCER; PELVIS SURGERY; POSTMENOPAUSE; PRIORITY JOURNAL; PROCTOCOLECTOMY; PUERPERIUM; QUALITY OF LIFE; REVIEW; RISK FACTOR; SEXUAL AROUSAL DISORDER; SIDE EFFECT; SURGICAL TECHNIQUE; VAGINA RING; VAGINISM; WEIGHT GAIN;

DISEASE MANAGEMENT; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 35648940758     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.09.012     Document Type: Review

References (102)

1. Basson R., Berman J., Burnett A., Derogatis L., Ferguson D., Fourcroy J., et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 163 (2000) 888-893
2. Laumann E.O., Paik A., and Rosen R.C. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281 (1999) 537-544
3. Salonia A., Munarriz R.M., Naspro R., Nappi R.E., Briganti A., Chionna R., et al. Women's sexual dysfunction: a pathophysiological review. BJU Int 93 (2004) 1156-1164
4. Berman J.R., Berman L.A., Werbin T.J., and Goldstein I. Female sexual dysfunction: anatomy, physiology, evaluation and treatment options. Curr Opin Urol 9 (1999) 563-568
5. Basson R. Using a different model for female sexual response to address women's problematic low sexual desire. Sex Marital Ther 27 (2001) 395-403
6. Bachmann G.A., and Leiblum S.R. The impact of hormones on menopausal sexuality: a literature review. Menopause 11 (2004) 120-130
7. Warnock J.K., Bundren J.C., and Morris D.W. Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues. J Sex Marital Ther 33 (1997) 761-766
8. Segraves R.T. Female sexual disorders: psychiatric aspects. Can J Psychiatry 47 (2002) 419-425
9. Basson R., McInnes R., Smith M.D., Hodgson G., and Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med 11 (2002) 367-377
10. Rosen R.C. Prevalence and risk factors of sexual dysfunction in men and women. Curr Psychiatry Rep 2 (2000) 189-195
11. Rosen R.C., Lane R.M., and Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 19 (1999) 67-85
12. Spector I.P., and Carey M.P. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav 19 (1990) 389-408
13. Fry R.P., Crisp A.H., and Beard R.W. Sociopsychological factors in chronic pelvic pain: a review. J Psychosom Res 42 (1997) 1-15
14. Pauls R.N., and Berman J.R. Impact of pelvic floor disorders and prolapse on female sexual function and response. Urol Clin North Am 29 (2002) 677-683
15. Salonia A., Zanni G., Nappi R.E., Briganti A., Deho F., Fabbri F., et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results of a cross-sectional study. Eur Urol 45 (2004) 642-648 discussion 648
16. Sarrel P.M. Ovarian hormones and vaginal blood flow: using laser Doppler velocimetry to measure effects in a clinical trial of post-menopausal women. Int J Impot Res 10 Suppl 2 (1998) S91-S93 discussion S98-101
17. Berman J.R., and Goldstein I. Female sexual dysfunction. Urol Clin North Am 28 (2001) 405-416
18. Davison S.L., and Davis S.R. Androgens in women. J Steroid Biochem Mol Biol 85 (2003) 363-366
19. Sherwin B.B., and Gelfand M.M. Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 151 (1985) 153-160
20. Rako S. Testosterone supplemental therapy after hysterectomy with or without concomitant oophorectomy: estrogen alone is not enough. J Womens Health Gend Based Med 9 (2000) 917-923
21. Sipski M.L., Alexander C.J., and Rosen R.C. Orgasm in women with spinal cord injuries: a laboratory-based assessment. Arch Phys Med Rehabil 76 (1995) 1097-1102
22. Sipski M.L., Alexander C.J., and Rosen R.C. Physiological parameters associated with psychogenic sexual arousal in women with complete spinal cord injuries. Arch Phys Med Rehabil 76 (1995) 811-818
23. Berard E.J. The sexuality of spinal cord injured women: physiology and pathophysiology. A review. Paraplegia 27 (1989) 99-112
24. Sipski M.L., Alexander C.J., and Rosen R. Sexual arousal and orgasm in women: effects of spinal cord injury. Ann Neurol 49 (2001) 35-44
25. Charlifue S.W., Gerhart K.A., Menter R.R., Whiteneck G.G., and Manley M.S. Sexual issues of women with spinal cord injuries. Paraplegia 30 (1992) 192-199
26. Whipple B., and Komisaruk B.R. Sexuality and women with complete spinal cord injury. Spinal Cord 35 (1997) 136-138
27. Litwiller S.E., Frohman E.M., and Zimmern P.E. Multiple sclerosis and the urologist. J Urol 161 (1999) 743-757
28. Zorzon M., Zivadinov R., Bosco A., Bragadin L.M., Moretti R., Bonfigli L., et al. Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups. Mult Sler 5 (1999) 418-427
29. Benet A.E., and Melman A. The epidemiology of erectile dysfunction. Urol Clin North Am 22 (1995) 699-709
30. Goldstein I., and Berman J.R. Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndromes. Int J Impot Res 10 Suppl 2 (1998) S84-S90 discussion S98-101
31. Park K., Goldstein I., Andry C., Siroky M.B., Krane R.J., and Azadzoi K.M. Vasculogenic female sexual dysfunction: the hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res 9 (1997) 27-37
32. Lepine L.A., Hillis S.D., Marchbanks P.A., Koonin L.M., Morrow B., Kieke B.A., et al. Hysterectomy surveillance-United States, 1980-1993. MMWR CDC Surveill Summ 46 (1997) 1-15
33. Dennerstein L., Wood C., and Burrows G.D. Sexual response following hysterectomy and oophorecomy. Obstet Gynecol 49 (1977) 92-96
34. Dennerstein L., Wood G., and Burrows G.D. Sexual dysfunction following hysterectomy. Sexual dysfunction following hysterectomy Aust Fam Physician 6 (1977) 535-543
35. Helstrom L. Sexuality after hysterectomy: a model based on quantitative and qualitative analysis of 104 women before and after subtotal hysterectomy. J Psychosom Obstet Gynaecol 15 (1994) 219-229
36. Dodds D.T., Potgieter C.R., Turner P.J., and Scheepers G.P. The physical and emotional results of hysterectomy: a review of 162 cases. S Afr Med J 35 (1961) 53-54
37. Alexander D.A., Naji A.A., Pinion S.B., Mollison J., Kitchener H.C., Parkin D.E., et al. Randomised trial comparing hysterectomy with endometrial ablation for dysfunctional uterine bleeding: psychiatric and psychosocial aspects. BMJ 312 (1996) 280-284
38. Rhodes J.C., Kjerulff K.H., Langenberg P.W., and Guzinski G.M. Hysterectomy and sexual functioning. JAMA 282 (1999) 1934-1941
39. Dragisic K.G., and Milad M.P. Sexual functioning and patient expectations of sexual functioning after hysterectomy. Am J Obstet Gynecol 190 (2004) 1416-1418
40. El-Toukhy T.A., Hefni M., Davies A., and Mahadevan S. The effect of different types of hysterectomy on urinary and sexual functions: a prospective study. J Obstet Gynaecol 24 (2004) 420-425
41. Roovers J.P., van der Bom J.G., van der Vaart C.H., and Heintz A.P. Hysterectomy and sexual wellbeing: prospective observational study of vaginal hysterectomy, subtotal abdominal hysterectomy, and total abdominal hysterectomy. BMJ 327 (2003) 774-778
42. Kilkku P. Supravaginal uterine amputation versus hysterectomy with reference to subjective bladder symptoms and incontinence. Acta Obstet Gynecol Scand 64 (1985) 375-379
43. Thakar R., Ayers S., Clarkson P., Stanton S., and Manyonda I. Outcomes after total versus subtotal abdominal hysterectomy. N Engl J Med 347 (2002) 1318-1325
44. Learman L.A., Summitt Jr. R.L., Varner R.E., McNeeley S.G., Goodman-Gruen D., Richter H.E., et al. A randomized comparison of total or supracervical hysterectomy: surgical complications and clinical outcomes. Obstet Gynecol 102 (2003) 453-462
45. Bergmark K., Avall-Lundqvist E., Dickman P.W., Henningsohn L., and Steineck G. Patient-rating of distressful symptoms after treatment for early cervical cancer. Acta Obstet Gynecol Scand 81 (2002) 443-450
46. Jensen P.T., Groenvold M., Klee M.C., Thranov I., Petersen M.A., and Machin D. Early-stage cervical carcinoma, radical hysterectomy, and sexual function. A longitudinal study. Cancer 100 (2004) 97-106
47. Auchincloss S.S. After treatment. Psychosocial issues in gynecologic cancer survivorship. Cancer 76 (1995) 2117-2124
48. Andersen B.L. Quality of life for women with gynecologic cancer. Curr Opin Obstet Gynecol 7 (1995) 69-76
49. Carmack Taylor C.L., Basen-Engquist K., Shinn E.H., and Bodurka D.C. Predictors of sexual functioning in ovarian cancer patients. J Clin Oncol 22 (2004) 881-889
50. Stewart D.E., Wong F., Duff S., Melancon C.H., and Cheung A.M. "What doesn't kill you makes you stronger": an ovarian cancer survivor survey. Gynecol Oncol 83 (2001) 537-542
51. Hockel M., Konerding M.A., and Heussel C.P. Liposuction-assisted nerve-sparing extended radical hysterectomy: oncologic rationale, surgical anatomy, and feasibility study. Am J Obstet Gynecol 178 (1998) 971-976
52. Hoffman M.S. Extent of radical hysterectomy: evolving emphasis. Gynecol Oncol 94 (2004) 1-9
53. Stein J.P., and Skinner D.G. Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer. BJU Int 92 (2003) 12-17
54. Nordstrom G.M., and Nyman C.R. Male and female sexual function and activity following ileal conduit urinary diversion. Br J Urol 70 (1992) 33-39
55. Berman L., Berman J., Felder S., Pollets D., Chhabra S., Miles M., et al. Seeking help for sexual function complaints: what gynecologists need to know about the female patient's experience. Fertil Steril 79 (2003) 572-576
56. Stenzl A., Colleselli K., Poisel S., Feichtinger H., Pontasch H., and Bartsch G. Rationale and technique of nerve sparing radical cystectomy before an orthotopic neobladder procedure in women. J Urol 154 (1995) 2044-2049
57. Stenzl A., Colleselli K., Poisel S., Feichtinger H., and Bartsch G. Anterior exenteration with subsequent ureteroileal urethrostomy in females. Anatomy, risk of urethral recurrence, surgical technique, and results. Eur Urol 33 Suppl 4 (1998) 18-20
58. Bjerre B.D., Johansen C., and Steven K. A questionnaire study of sexological problems following urinary diversion in the female patient. Scand J Urol Nephrol 31 (1997) 155-160
59. Zippe C.D., Raina R., Shah A.D., Massanyi E.Z., Agarwal A., Ulchaker J., et al. Female sexual dysfunction after radical cystectomy: a new outcome measure. Urology 63 (2004) 1153-1157
60. Burkhard F.C., and Studer U.E. Orthotopic bladder substitution. Curr Opin Urol 10 (2000) 343-349
61. Kessler T.M., Burkhard F.C., Perimenis P., Danuser H., Thalmann G.N., Hochreiter W.W., et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 172 (2004) 1323-1327
62. Schoenberg M., Hortopan S., Schlossberg L., and Marshall F.F. Anatomical anterior exenteration with urethral and vaginal preservation: illustrated surgical method. J Urol 161 (1999) 569-572
63. Banerjee A.K. Sexual dysfunction after surgery for rectal cancer. Lancet 353 (1999) 1900-1902
64. Enker W.E. Total mesorectal excision-the new golden standard of surgery for rectal cancer. Ann Med 29 (1997) 127-133
65. Enker W.E., Havenga K., Polyak T., Thaler H., and Cranor M. Abdominoperineal resection via total mesorectal excision and autonomic nerve preservation for low rectal cancer. World J Surg 21 (1997) 715-720
66. Pocard M., Zinzindohoue F., Haab F., Caplin S., Parc R., and Tiret E. A prospective study of sexual and urinary function before and after total mesorectal excision with autonomic nerve preservation for rectal cancer. Surgery 131 (2002) 368-372
67. Quah H.M., Jayne D.G., Eu K.W., and Seow-Choen F. Bladder and sexual dysfunction following laparoscopically assisted and conventional open mesorectal resection for cancer. Br J Surg 89 (2002) 1551-1556
68. Bretschneider J.G., and McCoy N.L. Sexual interest and behavior in healthy 80- to 102-year-olds. Arch Sex Behav 17 (1988) 109-129
69. Marsiglio W., and Donnelly D. Sexual relations in later life: a national study of married persons. J Gerontol 46 (1991) S338-S344
70. Hicks T.L., Goodall S.F., Quattrone E.M., and Lydon-Rochelle M.T. Postpartum sexual functioning and method of delivery: summary of the evidence. J Midwifery Womens Health 49 (2004) 430-436
71. Glazener C.M. Sexual function after childbirth: women's experiences, persistent morbidity and lack of professional recognition. Br J Obstet Gynaecol 104 (1997) 330-335
72. Johanson R., Wilkinson P., Bastible A., Ryan S., Murphy H., and O'Brien S. Health after childbirth: a comparison of normal and assisted vaginal delivery. Midwifery 9 (1993) 161-168
73. Buhling K.J., Schmidt S., Robinson J.N., Klapp C., Siebert G., and Dudenhausen J.W. Rate of dyspareunia after delivery in primiparae according to mode of delivery. Eur J Obstet Gynecol Reprod Biol 124 (2006) 42-46
74. Signorello L.B., Harlow B.L., Chekos A.K., and Repke J.T. Postpartum sexual functioning and its relationship to perineal trauma: a retrospective cohort study of primiparous women. Am J Obstet Gynecol 184 (2001) 881-888 discussion 888-90
75. Rosen R., Brown C., Heiman J., Leiblum S., Meston C., Shabsigh R., et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26 (2000) 191-208
76. Mazer N.A., Leiblum S.R., and Rosen R.C. The brief index of sexual functioning for women (BISF-W): a new scoring algorithm and comparison of normative and surgically menopausal populations. Menopause 7 (2000) 350-363
77. Fourcroy J.L. Female sexual dysfunction: potential for pharmacotherapy. Drugs 63 (2003) 1445-1457
78. Burkman R.T., Collins J.A., and Greene R.A. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol 185 (2001) S13-S23
79. Cardozo L., Bachmann G., McClish D., Fonda D., and Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol 92 (1998) 722-727
80. Collins A., and Landgren B.M. Reproductive health, use of estrogen and experience of symptoms in perimenopausal women: a population-based study. Maturitas 20 (1994) 101-111
81. Basson R. Female sexual response: the role of drugs in the management of sexual dysfunction. Obstet Gynecol 98 (2001) 350-353
82. Montgomery J.C., Appleby L., Brincat M., Versi E., Tapp A., Fenwick P.B., et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1 (1987) 297-299
83. Robinson D., and Cardozo L.D. The role of estrogens in female lower urinary tract dysfunction. Urology 62 (2003) 45-51
84. Kaplan S.A., Reis R.B., Kohn I.J., Ikeguchi E.F., Laor E., Te A.E., et al. Safety and efficacy of sildenafil in postmenopausal women with sexual dysfunction. Urology 53 (1999) 481-486
85. Berman J.R., Berman L.A., Lin H., Flaherty E., Lahey N., Goldstein I., et al. Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder. J Sex Marital Ther 27 (2001) 411-420
86. Sipski M.L., Rosen R.C., Alexander C.J., and Hamer R.M. Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury. Urology 55 (2000) 812-815
87. Rosen R.C., Phillips N.A., Gendrano III N.C., and Ferguson D.M. Oral phentolamine and female sexual arousal disorder: a pilot study. J Sex Marital Ther 25 (1999) 137-144
88. Michelson D., Kociban K., Tamura R., and Morrison M.F. Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. J Psychiatr Res 36 (2002) 147-152
89. Walsh K.E., and Berman J.R. Sexual dysfunction in the older woman: an overview of the current understanding and management. Drugs Aging 21 (2004) 655-675
90. Wilson S.K., Delk II J.R., and Billups K.L. Treating symptoms of female sexual arousal disorder with the Eros-Clitoral Therapy Device. J Gend Specif Med 4 (2001) 54-58
91. Leiblum S., Brown C., Wan J., and Rawlinson L. Persistent sexual arousal syndrome: a descriptive study. J Sex Med 2 (2005) 331-337
92. Kabakci E., and Batur S. Who benefits from cognitive behavioral therapy for vaginismus?. J Sex Marital Ther 29 (2003) 277-288
93. Gehring D. Couple therapy for low sexual desire: a systemic approach. J Sex Marital Ther 29 (2003) 25-38
94. Marks I.M. Review of behavioral psychotherapy, II: sexual disorders. Am J Psychiatry 138 (1981) 750-756
95. Tullman G.M., Gilner F.H., Kolodny R.C., Dornbush R.L., and Tullman G.D. The pre- and post-therapy measurement of communication skills of couples undergoing sex therapy at the Masters & Johnson Institute. Arch Sex Behav 10 (1981) 95-109
96. Master W.H., and Johnson V.E. Principles of the new sex therapy. Am J Psychiatry 133 (1976) 548-554
97. Horenblas S., Meinhardt W., Ijzerman W., and Moonen L.F. Sexuality preserving cystectomy and neobladder: initial results. J Urol 166 (2001) 837-840
98. Havenga K., Enker W.E., McDermott K., Cohen A.M., Minsky B.D., and Guillem J. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 182 (1996) 495-502
99. Chatwin N.A., Ribordy M., and Givel J.C. Clinical outcomes and quality of life after low anterior resection for rectal cancer. Eur J Surg 168 (2002) 297-301
100. Lobo R.A., Rosen R.C., Yang H.M., Block B., and Van Der Hoop R.G. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 79 (2003) 1341-1352
101. Rioux J.E., Devlin C., Gelfand M.M., Steinberg W.M., and Hepburn D.S. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis. Menopause 7 (2000) 156-161
102. Ayton R.A., Darling G.M., Murkies A.L., Farrell E.A., Weisberg E., Selinus I., et al. A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy. Br J Obstet Gynaecol 103 (1996) 351-358